BelgiumNetherlandsSwedenProof of Principle of the best-in-class therapeutic mRNA cancer vaccine

July 19, 2022by pcdata0

Dates: 01/02/2021
31/07/2025


Topic: Tool


Project type: Clinic
Theranostic
Immunotherapy


Project target: Cancer Vaccines


Financing:

H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being
H2020-EU.3.1.3. – Treating and managing disease
Other


Participating agents:

ETHERNA IMMUNOTHERAPIES


Keywords: vaccine; oncoology; HPV16; RNA;


Countries: Belgium; Sweden; Netherlands


Project page: Access page

 

Leave a Reply

Your email address will not be published. Required fields are marked *